Using brain stimulation to reduce cravings in methamphetamine users
Official title: The Use of Repetitive Transmagnetic Stimulation to Target Craving in Methamphetamine Use Disorder
Run by Oregon Health and Science University · NCT03470480 · Data updated 2026-11-12
This study tests whether a type of brain stimulation can help reduce cravings for methamphetamine in adults who are trying to stay off the drug.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Oregon Health and Science University Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Status | Recruiting |
| Started | February 7, 2018 |
| Main results expected | September 1, 2027 |
| Study ends | September 1, 2027 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT03470480 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a history of methamphetamine use disorder who have recently abstained from methamphetamine and are motivated to quit.
✕Probably not a fit
Patients with significant psychiatric disorders or other substance use disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project investigates the effects of high frequency repetitive transmagnetic stimulation (HF-rTMS) on cue-induced cravings in adults with methamphetamine use disorder. Participants who have recently abstained from methamphetamine will be randomly assigned to receive either real or sham rTMS while being exposed to methamphetamine-related or neutral visual cues. The study aims to determine if stimulation of the left dorsolateral prefrontal cortex can effectively reduce cravings for methamphetamine. The outcomes will be measured using validated craving assessments.
Why it matters
Potential benefit: If successful, this approach could provide a novel non-pharmacological treatment option for individuals struggling with methamphetamine addiction.
How similar studies have gone: While the use of rTMS in addiction treatment is still emerging, preliminary studies have shown promise in reducing cravings for various substances.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Subjects must use at least 0.5 g per day at least 5 days per week and have a minimum 12-month history of METH abuse.
* Subjects must meet DSM V diagnosis for methamphetamine use disorder.
* Subjects must have a minimum 4-week period of detoxification and a desire to stop using methamphetamine.
Exclusion Criteria:
* Present or past history of neurological disorder
* The present history of a DSM IV Axis I or DSM V primary psychiatric disease (apart from MUD and depressive symptoms defined as a Hamilton Depression Scale Score \< 7 ("normal"))
* Scores on the Hamilton Depression Scale \> 8, possibly indicating clinical depression
* No current abuse of drugs other than methamphetamine (except nicotine). Urine-screening tests for psychoactive drugs will be performed to corroborate the lack of drug use.
* Individuals meeting criteria for cannabis use disorder or alcohol use disorder
* Medical illness that can affect brain function
* Past or present history of cardiovascular disease or high blood pressure
* Any history of epilepsy or a known history of seizure disorder
* A history of metal in the head or chest area (except dental fillings or braces)
* Current consumption of psychiatric medication
* Any other medical, neurological or neurosurgical condition that would preclude the administration of repetitive transmagnetic stimulation
Where it's running
-
Veterans Affairs Portland Health Care System
Portland, Oregon, United States Recruiting
Study contacts
- Study coordinator: Brandon J Cornejo, MD, PhD
- Email: brandon.cornejo@va.gov
- Phone: 503-721-7964
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Long-term high-dose lisdexamfetamine treatment for methamphetamine use disorder
This trial will try giving adults with moderate to severe methamphetamine use disorder a 25-week course of high-dose lisdexamfetamine plus their usual care to see if it helps them stay in treatment and cut down on methamphetamine use compared with placebo.
-
Investigating how Pavlovian mechanisms influence substance use behaviors
This study is testing how certain learned responses might affect substance use behaviors in people with moderate to severe substance use disorders compared to healthy individuals.
-
High dose stimulant treatment for methamphetamine users
This study is testing whether a high dose of a medication called lisdexamfetamine, along with support and rewards, can help adults who use methamphetamine reduce their drug use more effectively than standard treatment alone.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Effects of comorbidity on people with severe mental illness
This study tests how having both alcohol/substance use and a severe mental illness affects hospitalizations, medications, and social participation among adults followed at a mental health center.
-
Network-guided, personalized brain stimulation for behavioral symptoms in Alzheimer's disease
This trial tests whether personalized network-guided rTMS can help reduce behavioral and psychological symptoms in people with Alzheimer's disease who meet eligibility criteria.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.